Real-life Experience with Ceftolozane/tazobactam in Canada: Results from the CLEAR (canadian LEadership on Antimicrobial Real-life Usage) Registry
JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE(2021)
摘要
•Use of ceftolozane/tazobactam (C/T) in Canadian patients using data captured by the CLEAR registry.•C/T is used as directed therapy to treat a variety of severe infections caused multidrug-resistant Pseudomonas aeruginosa.•C/T is commonly used combined with other antimicrobials, with relatively high cure rates and an excellent safety profile.
更多查看译文
关键词
Ceftolozane/tazobactam,CLEAR,Efficacy,Adverse effect,Pneumonia,Bacteraemia
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要